Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centrus Energy Corp (LEU) vs Smith & Nephew plc (SNN) Price & Performance

Centrus Energy CorpTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Centrus Energy Corp vs Smith & Nephew plc — how do they compare? Centrus Energy Corp trades at $165.13 (market cap $3.08B), while Smith & Nephew plc trades at $30.12 (market cap $12.64B). The key difference: Smith & Nephew plc is far larger — about 4.1× Centrus Energy Corp's market cap, and Smith & Nephew plc pays a 2.57% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals.

LEUSNN
Market Cap
$3.08B$12.64B
Sector
EnergyHealth
52-Week High
$436.00$38.70
52-Week Low
$146.61$28.73
Enterprise Value
$2.39B$15.41B
Dividend Yield
2.57%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centrus Energy Corp

Centrus Energy (LEU) trades at $156.39, showing modest daily gains amid a bearish technical outlook. The company reported mixed quarterly earnings, with a recent beat in Q1 2026 but misses in prior quarters. Positive developments include a $1 billion+ DOE contract and inclusion in the S&P SmallCap 600, highlighting its strategic role in the U.S. nuclear fuel supply chain. Valuation ratios remain elevated, with a P/E of 56.75, while profitability metrics like a 13.4% net income margin reflect solid operational performance.

The outlook for LEU is cautiously optimistic, driven by government contracts and nuclear energy tailwinds, but high valuation and recent earnings volatility pose risks. Analyst consensus is mixed with a $223.14 price target, suggesting potential upside if execution improves. Key risks include dependency on federal contracts and competitive pressures in the uranium sector.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $30.43, down 0.54% on the day, with mixed technical signals showing a neutral overall stance. The company demonstrates improving fundamentals with 2024 revenue of $5.81 billion and net income of $412 million, representing a 7.09% margin. Recent product launches including the LYNX COBLATION Wand and CORI XT robotics platform highlight ongoing innovation. Cash flow trends show strong operational performance with $987 million from operations in 2024.

SNN presents a balanced investment case with improving profitability and product innovation offset by recent earnings misses. The stock trades at reasonable valuations (P/E 21.36, P/S 2.17) with analyst consensus leaning Hold (68%). Key risks include execution challenges and competitive pressures, while catalysts include robotics expansion and wound care leadership. The $500 million buyback program supports shareholder returns.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centrus Energy Corp

Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.

Read more on LEU

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN